Quantcast

Latest Amgen Stories

2014-06-16 08:29:32

The Lung-MAP trial uses a multi-drug, targeted screening approach to match patients with promising new cancer treatments based on their unique tumor profiles BETHESDA, Md., June 16,

2014-06-11 16:27:22

Phase 3 Program Underway to Further Assess Brodalumab as Potential Treatment for People Living With Psoriatic Arthritis THOUSAND OAKS, Calif.

2014-06-10 16:26:06

SANTA MONICA, Calif., June 10, 2014 /PRNewswire/ -- Kite Pharma, Inc., a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT(TM)) products

2014-06-09 16:25:38

THOUSAND OAKS, Calif., June 9, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the appointment of David W.

2014-06-06 16:23:57

THOUSAND OAKS, Calif., June 6, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Goldman Sachs Global Healthcare Conference at 1:20 p.m.

2014-06-02 08:30:06

New Chief Medical Officer Brings Wealth of Experience in Innovative Therapies in Oncology SANTA MONICA, Calif., June 2, 2014 /PRNewswire/ -- Kite Pharma, Inc., a clinical-stage biopharmaceutical

2014-06-02 08:29:32

Phase 1 Study Evaluating Talimogene Laherparepvec Plus Ipilimumab Showed Tolerability at Doses Administered THOUSAND OAKS, Calif., June 2, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN)

2014-06-01 12:20:22

Data From Phase 3 TESLA Study in Patients With Homozygous Familial Hypercholesterolemia (HoFH) and Phase 2/3 TAUSSIG Study in Patients With Severe Familial Hypercholesterolemia Presented in Late-Breaking

2014-05-31 08:21:10

Study Shows Improved Survival Benefit in Panitumumab Arm THOUSAND OAKS, Calif., May 31, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced results from the Phase 2 PEAK study that reinforce

2014-05-30 16:25:15

THOUSAND OAKS, Calif., May 30, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Jefferies 2014 Global Healthcare Conference at 11:30 a.m.


Word of the Day
ultimo
  • In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.
  • In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.
The word 'ultimo' comes from the Latin phrase 'ultimo mense', 'in the last month'.
Related